South Korea · Delayed Price · Currency is KRW Sewoon Medical Statistics
Total Valuation
Sewoon Medical has a market cap or net worth of KRW 117.10 billion. The enterprise value is 24.07 billion.
| Market Cap | 117.10B |
| Enterprise Value | 24.07B |
Important Dates
The next estimated earnings date is Friday, April 3, 2026.
| Earnings Date | Apr 3, 2026 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
Sewoon Medical has 43.29 million shares outstanding. The number of shares has decreased by -1.36% in one year.
| Current Share Class | 43.29M |
| Shares Outstanding | 43.29M |
| Shares Change (YoY) | -1.36% |
| Shares Change (QoQ) | -1.17% |
| Owned by Insiders (%) | 53.40% |
| Owned by Institutions (%) | 0.08% |
| Float | 20.17M |
Valuation Ratios
The trailing PE ratio is 9.70.
| PE Ratio | 9.70 |
| Forward PE | n/a |
| PS Ratio | 1.84 |
| PB Ratio | 0.76 |
| P/TBV Ratio | 0.78 |
| P/FCF Ratio | 7.28 |
| P/OCF Ratio | 6.59 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 1.50, with an EV/FCF ratio of 1.50.
| EV / Earnings | 2.02 |
| EV / Sales | 0.38 |
| EV / EBITDA | 1.50 |
| EV / EBIT | 1.90 |
| EV / FCF | 1.50 |
Financial Position
The company has a current ratio of 14.58, with a Debt / Equity ratio of 0.00.
| Current Ratio | 14.58 |
| Quick Ratio | 12.45 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.05 |
| Debt / FCF | 0.05 |
| Interest Coverage | 357.55 |
Financial Efficiency
Return on equity (ROE) is 8.04% and return on invested capital (ROIC) is 17.78%.
| Return on Equity (ROE) | 8.04% |
| Return on Assets (ROA) | 4.95% |
| Return on Invested Capital (ROIC) | 17.78% |
| Return on Capital Employed (ROCE) | 8.19% |
| Weighted Average Cost of Capital (WACC) | 7.16% |
| Revenue Per Employee | 370.10M |
| Profits Per Employee | 69.26M |
| Employee Count | 172 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 2.22 |
Taxes
In the past 12 months, Sewoon Medical has paid 2.71 billion in taxes.
| Income Tax | 2.71B |
| Effective Tax Rate | 18.18% |
Stock Price Statistics
The stock price has increased by +16.09% in the last 52 weeks. The beta is 0.53, so Sewoon Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.53 |
| 52-Week Price Change | +16.09% |
| 50-Day Moving Average | 2,494.60 |
| 200-Day Moving Average | 2,526.58 |
| Relative Strength Index (RSI) | 68.26 |
| Average Volume (20 Days) | 951,272 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sewoon Medical had revenue of KRW 63.66 billion and earned 11.91 billion in profits. Earnings per share was 279.00.
| Revenue | 63.66B |
| Gross Profit | 23.55B |
| Operating Income | 12.70B |
| Pretax Income | 14.90B |
| Net Income | 11.91B |
| EBITDA | 16.02B |
| EBIT | 12.70B |
| Earnings Per Share (EPS) | 279.00 |
Balance Sheet
The company has 97.02 billion in cash and 763.80 million in debt, with a net cash position of 96.26 billion or 2,223.56 per share.
| Cash & Cash Equivalents | 97.02B |
| Total Debt | 763.80M |
| Net Cash | 96.26B |
| Net Cash Per Share | 2,223.56 |
| Equity (Book Value) | 154.40B |
| Book Value Per Share | 3,610.85 |
| Working Capital | 120.30B |
Cash Flow
In the last 12 months, operating cash flow was 17.77 billion and capital expenditures -1.69 billion, giving a free cash flow of 16.08 billion.
| Operating Cash Flow | 17.77B |
| Capital Expenditures | -1.69B |
| Depreciation & Amortization | 3.32B |
| Net Borrowing | -252.41M |
| Free Cash Flow | 16.08B |
| FCF Per Share | 371.50 |
Margins
Gross margin is 36.99%, with operating and profit margins of 19.95% and 18.71%.
| Gross Margin | 36.99% |
| Operating Margin | 19.95% |
| Pretax Margin | 23.41% |
| Profit Margin | 18.71% |
| EBITDA Margin | 25.17% |
| EBIT Margin | 19.95% |
| FCF Margin | 25.26% |
Dividends & Yields
This stock pays an annual dividend of 60.00, which amounts to a dividend yield of 2.22%.
| Dividend Per Share | 60.00 |
| Dividend Yield | 2.22% |
| Dividend Growth (YoY) | 16.67% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 21.80% |
| Buyback Yield | 1.36% |
| Shareholder Yield | 3.65% |
| Earnings Yield | 10.17% |
| FCF Yield | 13.73% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 24, 2009. It was a forward split with a ratio of 2.
| Last Split Date | Sep 24, 2009 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Sewoon Medical has an Altman Z-Score of 9.64 and a Piotroski F-Score of 6.
| Altman Z-Score | 9.64 |
| Piotroski F-Score | 6 |